Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Claudepierre

Showing results (111-120 of 154) with videos related to

Pageof 16
Sort By:
The Journal of Rheumatology|February 15, 2024
Erosions on T1-Weighted Magnetic Resonance Imaging Versus Radiography of Sacroiliac Joints in Recent-Onset Axial Spondyloarthritis: 2-Year Data (EMBARK Trial and DESIR Cohort)Walter P Maksymowych, Pascal Claudepierre, Manouk de Hooge, et al.
The Journal of Rheumatology|April 17, 2017
Takayasu Arteritis and Spondyloarthritis: Coincidence or Association? A Study of 14 CasesElodie Rivière, Laurent Arnaud, Mikael Ebbo, et al.
Arthritis Research & Therapy|January 30, 2021
Structural changes in the sacroiliac joint on MRI and relationship to ASDAS inactive disease in axial spondyloarthritis: a 2-year study comparing treatment with etanercept in EMBARK to a contemporary control cohort in DESIRWalter P Maksymowych, Pascal Claudepierre, Manouk de Hooge, et al.
Joint Bone Spine|June 26, 2007
Pharmacotherapy (excluding biotherapies) for ankylosing spondylitis: development of recommendations for clinical practice based on published evidence and expert opinionFrédéric Lavie, Stephan Pavy, Emmanuelle Dernis, et al.
Joint Bone Spine|June 27, 2007
Imaging for the diagnosis and follow-up of ankylosing spondylitis: development of recommendations for clinical practice based on published evidence and expert opinionStephan Pavy, Emmanuelle Dernis, Frédéric Lavie, et al.
Arthritis Research & Therapy|March 13, 2012
Is IL-6 an appropriate target to treat spondyloarthritis patients refractory to anti-TNF therapy? A multicentre retrospective observational studyFernando Kemta Lekpa, Cécile Poulain, Daniel Wendling, et al.
RMD Open|December 10, 2016
What is the reliability of non-trained investigators in recognising structural MRI lesions of sacroiliac joints in patients with recent inflammatory back pain? Results of the DESIR cohortCharlotte Jacquemin, Roxana Rubio Vargas, Rosaline van den Berg, et al.
The Journal of Rheumatology|July 15, 2022
Development and Validation of a Self-Administered Questionnaire Measuring Essential Knowledge in Patients With Axial SpondyloarthritisCatherine Beauvais, Bruno Pereira, Thao Pham, et al.
Joint Bone Spine|May 22, 2009
Pharmacological treatment (biotherapy excluded) of peripheral psoriatic arthritis: development of recommendations for clinical practice based on data from the literature and experts opinionEmmanuelle Dernis, Frédéric Lavie, Carine Salliot, et al.
Joint Bone Spine|July 18, 2006
TNFalpha antagonist therapy in ankylosing spondylitis and psoriatic arthritis: recommendations of the French Society for RheumatologyThao Pham, Francis Guillemin, Pascal Claudepierre, et al.
Pageof 16

Showing results (111-120 of 154) with videos related to

Sort By:
Pageof 16
The Journal of Rheumatology|February 15, 2024
Erosions on T1-Weighted Magnetic Resonance Imaging Versus Radiography of Sacroiliac Joints in Recent-Onset Axial Spondyloarthritis: 2-Year Data (EMBARK Trial and DESIR Cohort)Walter P Maksymowych, Pascal Claudepierre, Manouk de Hooge, et al.
The Journal of Rheumatology|April 17, 2017
Takayasu Arteritis and Spondyloarthritis: Coincidence or Association? A Study of 14 CasesElodie Rivière, Laurent Arnaud, Mikael Ebbo, et al.
Arthritis Research & Therapy|January 30, 2021
Structural changes in the sacroiliac joint on MRI and relationship to ASDAS inactive disease in axial spondyloarthritis: a 2-year study comparing treatment with etanercept in EMBARK to a contemporary control cohort in DESIRWalter P Maksymowych, Pascal Claudepierre, Manouk de Hooge, et al.
Joint Bone Spine|June 26, 2007
Pharmacotherapy (excluding biotherapies) for ankylosing spondylitis: development of recommendations for clinical practice based on published evidence and expert opinionFrédéric Lavie, Stephan Pavy, Emmanuelle Dernis, et al.
Joint Bone Spine|June 27, 2007
Imaging for the diagnosis and follow-up of ankylosing spondylitis: development of recommendations for clinical practice based on published evidence and expert opinionStephan Pavy, Emmanuelle Dernis, Frédéric Lavie, et al.
Arthritis Research & Therapy|March 13, 2012
Is IL-6 an appropriate target to treat spondyloarthritis patients refractory to anti-TNF therapy? A multicentre retrospective observational studyFernando Kemta Lekpa, Cécile Poulain, Daniel Wendling, et al.
RMD Open|December 10, 2016
What is the reliability of non-trained investigators in recognising structural MRI lesions of sacroiliac joints in patients with recent inflammatory back pain? Results of the DESIR cohortCharlotte Jacquemin, Roxana Rubio Vargas, Rosaline van den Berg, et al.
The Journal of Rheumatology|July 15, 2022
Development and Validation of a Self-Administered Questionnaire Measuring Essential Knowledge in Patients With Axial SpondyloarthritisCatherine Beauvais, Bruno Pereira, Thao Pham, et al.
Joint Bone Spine|May 22, 2009
Pharmacological treatment (biotherapy excluded) of peripheral psoriatic arthritis: development of recommendations for clinical practice based on data from the literature and experts opinionEmmanuelle Dernis, Frédéric Lavie, Carine Salliot, et al.
Joint Bone Spine|July 18, 2006
TNFalpha antagonist therapy in ankylosing spondylitis and psoriatic arthritis: recommendations of the French Society for RheumatologyThao Pham, Francis Guillemin, Pascal Claudepierre, et al.
Pageof 16